These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28818396)

  • 21. Comparison of Vitek 2 YS08 with Sensititre YeastOne for Candida susceptibility testing.
    Wong KY; Gardam D; Boan P
    Pathology; 2019 Oct; 51(6):668-669. PubMed ID: 31470992
    [No Abstract]   [Full Text] [Related]  

  • 22. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
    Choukri F; Benderdouche M; Sednaoui P
    J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of strains of Candida spp. Isolated from catheters in UHC of Oran (Algeria): Identification and antifungal susceptibility.
    Bendjelloul M; Boucherit-Otmani Z; Boucherit K
    J Mycol Med; 2016 Sep; 26(3):212-6. PubMed ID: 27103075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and Fluconazole Susceptibility Profile of Candida spp. Clinical Isolates in a Brazilian Tertiary Hospital in Minas Gerais, Brazil.
    Neves-Junior A; Cartágenes-Pinto AC; Rocha DA; de Sá LF; Junqueira Mde L; Ferreira-Pereira A
    An Acad Bras Cienc; 2015 Aug; 87(2 Suppl):1349-59. PubMed ID: 26312420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and antifungal susceptibility of Candida species isolated from the urine of patients in a university hospital in Brazil.
    Lima GME; Nunes MO; Chang MR; Tsujisaki RAS; Nunes JO; Taira CL; Thomaz DY; Negro GMBD; Mendes RP; Paniago AMM
    Rev Inst Med Trop Sao Paulo; 2017 Dec; 59():e75. PubMed ID: 29267583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Posaconazole susceptibility of clinical yeast isolates determined by an agar diffusion and microdilution method.
    Carrillo-Muñoz AJ; Tur-Tur C; Quindós G; Eraso E; Del Valle O; Santos P; Estivill D; Guardia C; Hernández-Molina JM; Giusiano G
    Int J Antimicrob Agents; 2011 Mar; 37(3):271-3. PubMed ID: 21232923
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
    Ozcan SK; Mutlu B; Dündar D; Willke A
    Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of antifungal susceptibility testing in Candida isolates by Candifast and disk-diffusion method.
    Giri S; Kindo AJ
    Indian J Pathol Microbiol; 2014; 57(4):595-7. PubMed ID: 25308014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Candida infection in the intensive care unit: A study of antifungal susceptibility pattern of Candida species in Milad hospital, Tehran, Iran.
    Alimehr S; Shekari Ebrahim Abad H; Fallah F; Rahbar M; Mohammadzadeh M; Vossoghian S; Rafeei Tabatabaee S; Roudbary M; Zaini F
    J Mycol Med; 2015 Dec; 25(4):e113-7. PubMed ID: 26563641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluconazole susceptibility of 3,056 clinical isolates of Candida species from 2005 to 2009 in a tertiary-care hospital.
    Ying Y; Zhang J; Huang SB; Liu FD; Liu JH; Zhang J; Hu XF; Zhang ZQ; Liu X; Huang XT
    Indian J Med Microbiol; 2015; 33(3):413-5. PubMed ID: 26068346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological advances in the treatment of invasive candidiasis.
    Deck DH; Guglielmo BJ
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):137-49. PubMed ID: 16441215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between microdilution, E-test, and disk diffusion methods for antifungal susceptibility testing of posaconazole against Candida spp.
    Sims CR; Paetznick VL; Rodriguez JR; Chen E; Ostrosky-Zeichner L
    J Clin Microbiol; 2006 Jun; 44(6):2105-8. PubMed ID: 16757605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Etest and disk diffusion methods compared with broth microdilution antifungal susceptibility testing of clinical isolates of Candida spp. against posaconazole.
    Diekema DJ; Messer SA; Hollis RJ; Boyken LB; Tendolkar S; Kroeger J; Pfaller MA
    J Clin Microbiol; 2007 Jun; 45(6):1974-7. PubMed ID: 17301284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Species distribution and antifungal susceptibility patterns of Candida spp. bloodstream isolates from a Brazilian tertiary care hospital.
    Passos XS; Costa CR; Araújo CR; Nascimento ES; e Souza LK; Fernandes Ode F; Sales WS; Silva Mdo R
    Mycopathologia; 2007 Mar; 163(3):145-51. PubMed ID: 17334813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of voriconazole against Candida species isolated in Taiwan.
    Yang YL; Cheng HH; Lo HJ
    Int J Antimicrob Agents; 2004 Sep; 24(3):294-6. PubMed ID: 15325436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.
    Bedini A; Venturelli C; Mussini C; Guaraldi G; Codeluppi M; Borghi V; Rumpianesi F; Barchiesi F; Esposito R
    Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method.
    Kathuria S; Singh PK; Sharma C; Prakash A; Masih A; Kumar A; Meis JF; Chowdhary A
    J Clin Microbiol; 2015 Jun; 53(6):1823-30. PubMed ID: 25809970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Respiratory tract mycotic infection in phthisiological practice: species composition and susceptibility of the Candida clinical isolates to antifungal agents].
    Kul'ko AB; Mitrokhin SD; Moroz AM
    Antibiot Khimioter; 2005; 50(4):14-7. PubMed ID: 16392334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The distribution and drug susceptibilities of clinical Candida species in TSARY 2014.
    Zhou ZL; Lin CC; Chu WL; Yang YL; Lo HJ;
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):399-404. PubMed ID: 27717650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic susceptibility of Candida isolates in a tertiary care hospital in Southern India.
    Srinivasan L; Kenneth J
    Indian J Med Microbiol; 2006 Jan; 24(1):80-1. PubMed ID: 16505571
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.